Dr. Kamilla Ripkens
Consultor científico
Kamilla Ripkens obtained her master in medical biology and a Ph.D. in biology at the university Essen. During her studies, she focused on microbiology and epigenetics.
Since 2025, Kamilla Ripkens has been supporting the legal team as a scientific consultant, providing expertise in the scientific contents of case. Before joining HOYNG ROKH MONEGIER, she worked at a Center of Medical Biotechnology where she gained a strong background in basic research and gathered expertise in molecular and cancer cell biology.
-
PUBLICATIONS
- Rey J, Breiden M, Lux V, Bluemke A, Steindel M, Ripkens K, Möllers B, Bravo Rodriguez K, Boisguerin P, Volkmer R, Mieres-Perez J, Clausen T, Sanchez-Garcia E, Ehrmann M. An allosteric HTRA1-calpain 2 complex with restricted activation profile. Proc Natl Acad Sci U S A. 2022 Apr 5;119(14):e2113520119.
- Schmidt N, Irle I, Ripkens K, Lux V, Nelles J, Johannes C, Parry L, Greenow K, Amir S, Campioni M, Baldi A, Oka C, Kawaichi M, Clarke AR, Ehrmann M. Epigenetic silencing of serine protease HTRA1 drives polyploidy. BMC Cancer. 2016 Jul 7;16:399.
Contáctenos
Dirección:
Steinstraße 20
40212 Düsseldorf
Germany
Dirección:
Steinstraße 20
40212 Düsseldorf
Germany
Datos
Idiomas
English, German
Formación
University Duisburg-Essen, Centre of Medical Biotechnology, PhD (2015)
University Duisburg-Essen, M.Sc. in Medical Biology (2010)
Especialidad
n/a
Colegiación
n/a